Company · CIK 1997038
Iambic Therapeutics, Inc.
| CIK | 1997038 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | CA |
| Listed | IAM (Nasdaq) |
| First annual or quarterly report | none on EDGAR |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-299057 | 2026-09-21 | 2026-10-15 | 4 |
Filings
5| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-10-15 | 424B4Final prospectus | 333-299057 | 0001193125-26-422865 |
| 2026-10-14 | EFFECTDeclared effective | 333-299057 | 9999999995-26-003244 |
| 2026-10-08 | S-1/AAmendment | 333-299057 | 0001193125-26-417416 |
| 2026-09-21 | S-1Registration filed | 333-299057 | 0001193125-26-396704 |
| 2026-07-24 | DRSDraft made public | 377-09598 | 0001193125-26-315779 |